MedNews: Spectral AI (Nasdaq: MDAI) raises about $5 Million to strengthen its finances for an FDA Pathway
Spectral AI is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound decisions in
top of page
Strategists and Implementers
for growing companies globally
Recent Postings
Oct 94 min read
MedNews: Nyxoah raises $27 million for its breakthrough treatment alternatives for Obstructive Sleep Apnea through neuromodulation
Nyxoah is reinventing sleep for the billion people that suffer from obstructive sleep apnea (OSA).
Oct 32 min read
MedNews: Triveni Bio raises $115 million to develop therapeutics addressing immunological and inflammatory disorders
Using a genetics-informed, precision medicine approach, the company seeks to establish proof-of-concept early in drug development
Sep 93 min read
MedNews: CSA Medical raises $53 million to advance its RejuvenAir System utilizing liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis
This round will fund the company though expected FDA premarket approval and the building of a commercialization strategy
Aug 233 min read
MedNews: XII MEDICAL closes $45 million financing to advance its neuromodulation therapy for obstructive sleep apnea
It is estimated that 425 million people, globally, have moderate to severe obstructive sleep apnea
Aug 113 min read
MedNews: EHE Health, the leader in employer-based preventive healthcare is acquired by Consello Capital
EHE's comprehensive, evidence-based preventive care provides 100% of the recommended screenings, resulting in more health conditions being f
Aug 83 min read
TechNews: Cyclotron technology innovator and isotope manufacturer IONETIX closes financing led by Tees River and Eli Lilly and Company
distribution supply chain includes contract drug manufacturing and "white glove" distribution logistics, allowing global access...
Aug 43 min read
MedNews: Clinical biopharmaceutical company Sellas Life Sciences, focused on the development of novel therapies for a broad range of cancer indications, raises $21 million
SELLAS is a clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications
Jul 275 min read
MedNews: AI-enabled biotechnology company ReviR Therapeutics raises $30 million to advance oral genetic medicines for multiple CNS disorders
ReviR Therapeutics is a biopharmaceutical company focused on the development of RNA-targeting small molecule therapies
Jul 253 min read
MedNews: clinical-stage biotherapeutics company Rani Therapeutics, focused on the oral delivery of biologics and drugs, prices $10 million offering
Our mission is to improve the lives of millions of patients suffering from chronic conditions by replacing painful injections with a pill
Jul 63 min read
MedNews: Adult stem cell therapeutics developer BrainStorm Cell Therapeutics (Nasdaq: BCLI) raises $4 million
Autologous MSC-NTF cells have received Orphan Drug designation status from the FDA and the European Medicines Agency
Jun 304 min read
MedNews: Holoclara closes $16 Million financing to advance worm-derived therapies for allergic and autoimmune disease
The company’s discovery engine builds on Dr. Choe’s research uncovering a unique pheromone language shared by roundworms
Jun 183 min read
MedNews: Ehealth Technologies partners with CancerX and the White House cancer moonshot to boost cancer innovation
Our patented technology with embedded AI collects and clinically organizes patient data, including records, lab results, images...
Jun 164 min read
MedNews: Avinger (Nasdaq: AVGR) prices share and warrant offering of up to $24 million at $1.66 per share
Avinger is a medical device company that has developed the first image-guided, catheter-based system for patients with vascular disease.
Jun 145 min read
MedNews: InduPro raises $85 Million to advance next-generation, proximity-based protein therapeutics for the treatment of cancer and autoimmune diseases
The financing will support the advancement of the first expected clinical product candidate targeting cancer tissue
Jun 103 min read
MedNews: Employee well being technology provider Navigate Wellbeing partners with content solution provider Caravan Wellness to benefit employees
This collaboration focuses on innovative workplace wellness programs, financial well-being education, mental and emotional health...
Jun 83 min read
MedNews: Immuno-pharma research and development company, AIM ImmunoTech raises $2 million from one investor
The Company’s lead product is a first-in-class investigational drug for cancers, viral diseases and disorders of the immune system
Jun 63 min read
MedNews: BMI OrganBank announces promising preclinical kidney transplant data for a novel medical device to reduce the wait-list for organ transplants
BMI OrganBank develops novel perfusion systems that can preserve and recondition organs and tissues.
Jun 12 min read
MedNews: GRIT Biotechnology and Quangang Pharmaceutical partner to jointly develop a globally standardized IL-2 for solid tumor patients receiving T-cell therapy
Grit is a clinical stage cell therapy company leading the tumor infiltrating lymphocytes (TILs) therapy development
May 293 min read
MedNews: MediLink Therapeutics enters into a multi-target technology platform license with the immunotherapy company BioNTech (Nasdaq: BNTX) for therapies for cancer and other serious diseases
MediLink Therapeutics, founded in 2020, is a clinical stage biotech company dedicated to developing conjugated drugs
bottom of page